APG101

Results: 12



#Item
1Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer

Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2015-03-24 12:30:06
2No. 05 January 30, 2015 (Koh) Surface molecule promotes pancreatic cancer aggressiveness A protein on the surface of pancreatic cancer cells promotes metastasis and the ability

No. 05 January 30, 2015 (Koh) Surface molecule promotes pancreatic cancer aggressiveness A protein on the surface of pancreatic cancer cells promotes metastasis and the ability

Add to Reading List

Source URL: www.dkfz.de

Language: English - Date: 2015-02-06 09:59:34
3man looks out of the window trains

man looks out of the window trains

Add to Reading List

Source URL: www.onclive.com

Language: English - Date: 2014-05-16 13:04:39
4Microsoft Word - Aug 14 Kortliarova.docx

Microsoft Word - Aug 14 Kortliarova.docx

Add to Reading List

Source URL: unlockinglifescode.org

Language: English - Date: 2014-06-18 23:10:20
5Title: Adult Brain Tumor Consortium (ABTC) (Limited Competition UM1) (Reissued Limited Competition RFA) Contact: William C. Timmer, Ph.D.

Title: Adult Brain Tumor Consortium (ABTC) (Limited Competition UM1) (Reissued Limited Competition RFA) Contact: William C. Timmer, Ph.D.

Add to Reading List

Source URL: deainfo.nci.nih.gov

Language: English - Date: 2013-05-21 08:02:05
6Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified

Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified

Add to Reading List

Source URL: www.novocure.com

Language: English - Date: 2014-07-10 11:18:41
7Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Add to Reading List

Source URL: virtualtrials.com

Language: English - Date: 2011-12-03 17:34:25
8Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Add to Reading List

Source URL: www.virtualtrials.com

Language: English - Date: 2011-12-03 17:34:25
9MAGFORCE AG FIGHTING CANCER WITH NANO MEDICINE Ben J. Lipps

MAGFORCE AG FIGHTING CANCER WITH NANO MEDICINE Ben J. Lipps

Add to Reading List

Source URL: www.magforce.de

Language: English - Date: 2014-03-07 08:52:07
10CJNS-Long-term Glioblastoma Multiforme Survivors: a Population-based Study http://www.canjneurolsci.org/25augtoc/long.html

CJNS-Long-term Glioblastoma Multiforme Survivors: a Population-based Study http://www.canjneurolsci.org/25augtoc/long.html

Add to Reading List

Source URL: www.brainlife.org

Language: English - Date: 2008-05-16 04:01:20